July 6, 2020 / 11:37 AM / a month ago

BRIEF-ADC Therapeutics Says U.S. FDA Lifts Partial Clinical Hold On Phase 2 Trial Of Camidanlumab Tesirine

July 6 (Reuters) - ADC Therapeutics SA:

* ADC THERAPEUTICS ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION HAS LIFTED PARTIAL CLINICAL HOLD ON PIVOTAL PHASE 2 CLINICAL TRIAL OF CAMIDANLUMAB TESIRINE

* ADC THERAPEUTICS SA - PIVOTAL PHASE 2 TRIAL IS INTENDED TO SUPPORT SUBMISSION OF A BIOLOGICS LICENSE APPLICATION TO FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below